PCUMex调查:墨西哥泌尿科医生在前列腺癌治疗中的争议

C.I. Villeda-Sandoval, J.A. Rivera-Ramírez, G. Romero-Veléz, A. Lisker-Cervantes, R.A. Castillejos-Molina, M.S. de Zavaleta
{"title":"PCUMex调查:墨西哥泌尿科医生在前列腺癌治疗中的争议","authors":"C.I. Villeda-Sandoval,&nbsp;J.A. Rivera-Ramírez,&nbsp;G. Romero-Veléz,&nbsp;A. Lisker-Cervantes,&nbsp;R.A. Castillejos-Molina,&nbsp;M.S. de Zavaleta","doi":"10.1016/j.uromx.2015.12.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Prostate cancer is the first cause of mortality related to malignancy in Mexican men. Common clinical practice has to be evaluated in order to gain a picture of reality apart from the guidelines.</p></div><div><h3>Aim</h3><p>To analyze clinical practice among urologists in Mexico in relation to prostate cancer management and to compare the results with current recommendations and guidelines.</p></div><div><h3>Methods</h3><p>We collected the data from 600 urologists, members of the <em>Sociedad Mexicana de Urología</em>, who were invited by email to answer a survey on their usual decisions when managing controversial aspects of prostate cancer patients.</p></div><div><h3>Results</h3><p>Quinolones were the most common antibiotic used as prophylaxis in prostate biopsy (75.51%); 10–12 cores were taken in more than 65% of prostate biopsies; and 18.27% of the participants performed limited pelvic lymphadenectomy. Treatment results showed that 10.75% of the urologists surveyed preferred radical prostatectomy as monotherapy in high-risk patients with extraprostatic extension and 60.47% used complete androgen deprivation in metastatic prostate cancer.</p></div><div><h3>Conclusions</h3><p>There are many areas of opportunity for improvement in our current clinical practice for the management of patients with prostate cancer.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2015.12.007","citationCount":"1","resultStr":"{\"title\":\"PCUMex survey: Controversies in the management of prostate cancer among Mexican urologists\",\"authors\":\"C.I. Villeda-Sandoval,&nbsp;J.A. Rivera-Ramírez,&nbsp;G. Romero-Veléz,&nbsp;A. Lisker-Cervantes,&nbsp;R.A. Castillejos-Molina,&nbsp;M.S. de Zavaleta\",\"doi\":\"10.1016/j.uromx.2015.12.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Prostate cancer is the first cause of mortality related to malignancy in Mexican men. Common clinical practice has to be evaluated in order to gain a picture of reality apart from the guidelines.</p></div><div><h3>Aim</h3><p>To analyze clinical practice among urologists in Mexico in relation to prostate cancer management and to compare the results with current recommendations and guidelines.</p></div><div><h3>Methods</h3><p>We collected the data from 600 urologists, members of the <em>Sociedad Mexicana de Urología</em>, who were invited by email to answer a survey on their usual decisions when managing controversial aspects of prostate cancer patients.</p></div><div><h3>Results</h3><p>Quinolones were the most common antibiotic used as prophylaxis in prostate biopsy (75.51%); 10–12 cores were taken in more than 65% of prostate biopsies; and 18.27% of the participants performed limited pelvic lymphadenectomy. Treatment results showed that 10.75% of the urologists surveyed preferred radical prostatectomy as monotherapy in high-risk patients with extraprostatic extension and 60.47% used complete androgen deprivation in metastatic prostate cancer.</p></div><div><h3>Conclusions</h3><p>There are many areas of opportunity for improvement in our current clinical practice for the management of patients with prostate cancer.</p></div>\",\"PeriodicalId\":34909,\"journal\":{\"name\":\"Revista mexicana de urologia\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.uromx.2015.12.007\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista mexicana de urologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2007408516000185\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista mexicana de urologia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2007408516000185","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

摘要

背景:前列腺癌是墨西哥男性恶性肿瘤死亡的第一大原因。必须对常见的临床实践进行评估,以便获得除指南之外的现实情况。目的分析墨西哥泌尿科医生在前列腺癌管理方面的临床实践,并将结果与目前的建议和指南进行比较。方法我们收集了600名泌尿科医生的数据,他们是墨西哥社会Urología的成员,我们通过电子邮件邀请他们回答一项关于他们在处理前列腺癌患者有争议方面的通常决定的调查。结果喹诺酮类药物是前列腺活检中预防使用最多的抗生素(75.51%);超过65%的前列腺活检取了10-12芯;18.27%的参与者行有限盆腔淋巴结切除术。治疗结果显示,10.75%的受访泌尿科医师首选根治性前列腺切除术作为前列腺外伸高危患者的单一治疗方法,60.47%的受访泌尿科医师选择完全雄激素剥夺治疗转移性前列腺癌。结论目前前列腺癌患者的临床治疗还有很多需要改进的地方。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
PCUMex survey: Controversies in the management of prostate cancer among Mexican urologists

Background

Prostate cancer is the first cause of mortality related to malignancy in Mexican men. Common clinical practice has to be evaluated in order to gain a picture of reality apart from the guidelines.

Aim

To analyze clinical practice among urologists in Mexico in relation to prostate cancer management and to compare the results with current recommendations and guidelines.

Methods

We collected the data from 600 urologists, members of the Sociedad Mexicana de Urología, who were invited by email to answer a survey on their usual decisions when managing controversial aspects of prostate cancer patients.

Results

Quinolones were the most common antibiotic used as prophylaxis in prostate biopsy (75.51%); 10–12 cores were taken in more than 65% of prostate biopsies; and 18.27% of the participants performed limited pelvic lymphadenectomy. Treatment results showed that 10.75% of the urologists surveyed preferred radical prostatectomy as monotherapy in high-risk patients with extraprostatic extension and 60.47% used complete androgen deprivation in metastatic prostate cancer.

Conclusions

There are many areas of opportunity for improvement in our current clinical practice for the management of patients with prostate cancer.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Revista mexicana de urologia
Revista mexicana de urologia Medicine-Urology
CiteScore
0.20
自引率
0.00%
发文量
49
期刊介绍: Revista Mexicana de Urología (RMU) [Mexican Journal of Urology] (ISSN: 0185-4542 / ISSN electronic: 2007-4085) is bimonthly publication that disseminates research by academicians and professionals of the international medical community interested in urological subjects, in the format of original articles, clinical cases, review articles brief communications and letters to the editor. Owing to its nature, it is publication with international scope that disseminates contributions in Spanish and English that are rigorously reviewed by peers under the double blind modality. Neither journalistic documents nor those that lack rigorous medical or scientific support are suitable for publication.
期刊最新文献
Fe de errores de «Resultados obtenidos con nefrolitotomía percutánea y su correlación con las escalas de Guy y S.T.O.N.E. en un hospital de la Ciudad de México» [Rev Mex Urol. 2016;76:331] Blindness due to a systemic fungal infection in a patient with a ureteral catheter Permixon® en el tratamiento de los síntomas del tracto urinario inferior por hiperplasia benigna de próstata: Nuevas aportaciones Resultados de la nefrectomía laparoscópica en pacientes obesos y no obesos Alfa-1 bloqueantes y resultados urodinámicos en varones con síntomas del tracto urinario inferior relacionados con obstrucción benigna de próstata: ¿fin de la controversia?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1